Zyprexa Competition

Zyprexa Competition

Over the last couple years, Zyprexa competitors have been making significant strides within the antipsychotic drug sales arena.  Since 2005, Johnson & Johnson's Risperdal (risperidone) has become the most widely prescribed antipsychotic (growing its US sales by 36% in 2005).  Also Pfizer's Geodon (ziprasidone) has experienced a 6% increase over the year-ago quarter with 32% annual growth, for the same year.